Comments on: Blackstone’s $2bn investment in Alnylam: betting on RNAi therapeutics /deals-analysis/blackstone-2bn-alnylam-deal/ The leading site for news and procurement in the pharmaceutical industry Wed, 15 Apr 2020 15:54:01 +0000 hourly 1 https://wordpress.org/?v=6.6.1